Investor Overview

VYNE Therapeutics® is a biopharmaceutical company.

Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.

NASDAQ-GS: VYNE

0.90

Jun. 23, 2025 13:29:52
  • Change 0.012 (1.34831%)
  • Volume 101,553
  • Today's Open 0.89
  • Previous Close 0.89
  • Today's High 0.93
  • Today's Low 0.89
  • 52 Week High 4.3
  • 52 Week Low 0.85